N'-[1-(2-chlorophenyl)-4-formyl-3-phenyl-1H-pyrazol-5-yl]-N,N-dimethyl-methanimidamide

ID: ALA1269986

PubChem CID: 52942243

Max Phase: Preclinical

Molecular Formula: C19H17ClN4O

Molecular Weight: 352.83

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)/C=N/c1c(C=O)c(-c2ccccc2)nn1-c1ccccc1Cl

Standard InChI:  InChI=1S/C19H17ClN4O/c1-23(2)13-21-19-15(12-25)18(14-8-4-3-5-9-14)22-24(19)17-11-7-6-10-16(17)20/h3-13H,1-2H3/b21-13+

Standard InChI Key:  NBIBJVOUIIPKCF-FYJGNVAPSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    4.6961   -5.1632    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5217   -5.0741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6841   -4.2724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9792   -3.8647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3607   -4.4216    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9763   -3.0372    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2630   -2.6216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2604   -1.7933    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6497   -4.0101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6510   -3.1837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9415   -2.7721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2235   -3.1845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2237   -4.0086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9379   -4.4208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9468   -5.7835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5418   -6.5057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9658   -7.2119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7916   -7.2005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1940   -6.4803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7693   -5.7711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5471   -1.3808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4433   -3.9358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1133   -4.4216    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9727   -1.3817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9378   -5.2446    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
 11 12  2  0
  4  6  1  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  6  7  2  0
  2 15  1  0
  2  3  1  0
 15 16  2  0
  7  8  1  0
 16 17  1  0
  3  4  2  0
 17 18  2  0
  5  9  1  0
 18 19  1  0
  4  5  1  0
 19 20  2  0
 20 15  1  0
  9 10  2  0
  8 21  1  0
  5  1  1  0
  3 22  1  0
 10 11  1  0
 22 23  2  0
  1  2  2  0
  8 24  1  0
 14 25  1  0
M  END

Associated Targets(Human)

NCI-H661 (425 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 352.83Molecular Weight (Monoisotopic): 352.1091AlogP: 4.23#Rotatable Bonds: 5
Polar Surface Area: 50.49Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.47CX LogP: 4.10CX LogD: 4.06
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.39Np Likeness Score: -1.09

References

1. Cheng KM, Huang YY, Huang JJ, Kaneko K, Kimura M, Takayama H, Juang SH, Wong FF..  (2010)  Synthesis and antiproliferative evaluation of N,N-disubstituted-N'-[1-aryl-1H-pyrazol-5-yl]-methnimidamides.,  20  (22): [PMID:20855206] [10.1016/j.bmcl.2010.08.133]

Source